Diethylcarbamazine overdosage

Revision as of 02:14, 7 January 2014 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Diethylcarbamazine
HETRAZAN® WHO Prescribing Information
Description
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overdosage

Nausea, vomiting, headache, dizziness and drowsiness are characteristic. In severe cases convulsions may occur, requiring treatment with parenteral diazepam. Treatment is otherwise supportive and symptomatic.[1]

References

  1. "WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Helminths: Lymphatic filariasis: Diethylcarbamazine".

Adapted from the FDA Package Insert.